{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T22:01:39Z","timestamp":1764194499494,"version":"3.41.2"},"reference-count":21,"publisher":"Rockefeller University Press","issue":"11","license":[{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.rupress.org\/terms\/"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":199,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,2]]},"abstract":"<jats:p>Over the past 9 mo, with 34 million infections and 1 million deaths, the COVID-19 pandemic has levied a grisly toll. Some countries, through political will and social organization, have successfully reduced the number of infections and deaths, but the global scale of loss reflects the difficulty of translating these approaches in other countries. An effective SARS-CoV-2 vaccine presents a technological solution to the failure of social and political ones. Vaccines are, however, not a silver bullet, but a safe, cost-effective, and globally applicable tool that will require a substantial effort\u2014cooperation, commitment, time, and funding\u2014to be effective.<\/jats:p>","DOI":"10.1084\/jem.20201288","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T13:07:21Z","timestamp":1602853641000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["SARS-CoV-2 vaccine development, access, and equity"],"prefix":"10.1084","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0461-6438","authenticated-orcid":true,"given":"Jerome H.","family":"Kim","sequence":"first","affiliation":[{"name":"International Vaccine Institute, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"291","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"2023072813041805300_bib1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4776","author":"Chandrashekar","year":"2020","journal-title":"Science."},{"year":"2020","author":"Chinazzi","key":"2023072813041805300_bib2"},{"key":"2023072813041805300_bib3","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00451-5","author":"Fontanet","year":"2020","journal-title":"Nat. Rev. Immunol."},{"year":"2020","author":"Food and Drug Administration","key":"2023072813041805300_bib4"},{"key":"2023072813041805300_bib5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01817","author":"Frederiksen","year":"2020","journal-title":"Front. Immunol."},{"key":"2023072813041805300_bib6","doi-asserted-by":"publisher","DOI":"10.17226\/25917","volume-title":"Framework for equitable allocation of COVID-19 vaccine.","author":"Gayle","year":"2020"},{"key":"2023072813041805300_bib7","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30346-2","author":"Gouglas","year":"2018","journal-title":"Lancet Glob. Health."},{"year":"2016","author":"International Vaccine Access Center","key":"2023072813041805300_bib8"},{"key":"2023072813041805300_bib9","doi-asserted-by":"publisher","DOI":"10.1126\/science.369.6511.1553","author":"Kupferschmidt","year":"2020","journal-title":"Science"},{"key":"2023072813041805300_bib20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.05.064","author":"Lambert","year":"2020","journal-title":"Vaccine"},{"key":"2023072813041805300_bib10","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-020-00151-8","author":"Le","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023072813041805300_bib11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2005630","author":"Lurie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2023072813041805300_bib12","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01083-20","author":"Moore","year":"2020","journal-title":"J. Virol."},{"key":"2023072813041805300_bib13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.10.046","author":"Plotkin","year":"2020","journal-title":"Vaccine."},{"key":"2023072813041805300_bib14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.15725","author":"Shah","year":"2020","journal-title":"JAMA."},{"key":"2023072813041805300_bib15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2027405","author":"Slaoui","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2023072813041805300_bib16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31354-4","author":"Usher","year":"2020","journal-title":"Lancet."},{"key":"2023072813041805300_bib17","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.05.002","author":"Vabret","year":"2020","journal-title":"Immunity."},{"year":"2020","author":"World Health Organization","key":"2023072813041805300_bib18"},{"key":"2023072813041805300_bib19","doi-asserted-by":"publisher","DOI":"10.12688\/gatesopenres.12817.1","author":"Young","year":"2018","journal-title":"Gates Open Res."},{"key":"2023072813041805300_bib21","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1800463","author":"Zellweger","year":"2020","journal-title":"Expert Rev.                        Vaccines"}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20201288\/1833431\/jem_20201288.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20201288\/1833431\/jem_20201288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T13:04:48Z","timestamp":1690549488000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/217\/11\/e20201288\/211470\/SARS-CoV-2-vaccine-development-access-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,2]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20201288","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"type":"print","value":"0022-1007"},{"type":"electronic","value":"1540-9538"}],"subject":[],"published":{"date-parts":[[2020,10,16]]},"article-number":"e20201288"}}